{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T18:44:19Z","timestamp":1772390659519,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-84444-7","type":"journal-article","created":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T03:55:49Z","timestamp":1735876549000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical impacts of Artocarpus lakoocha agglutinin-binding glycans for prognosis and treatment of cholangiocarcinoma"],"prefix":"10.1038","volume":"15","author":[{"given":"Phisit","family":"Sintusen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kulthida","family":"Vaeteewoottacharn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ubon","family":"Cha\u2019on","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chawalit","family":"Pairojkul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaiwat","family":"Aphivatanasiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sutas","family":"Suttiprapa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panupong","family":"Mahalapbutr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atit","family":"Silsirivanit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sopit","family":"Wongkham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sukanya","family":"Luang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,2]]},"reference":[{"key":"84444_CR1","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/jhbp.62","volume":"2","author":"P Sithithaworn","year":"2014","unstructured":"Sithithaworn, P., Yongvanit, P., Duenngai, K., Kiatsopit, N. & Pairojkul, C. Roles of liver fluke infection as risk factor for cholangiocarcinoma. J. Hepatobiliary Pancreat. Sci. 2, 301\u2013308 (2014).","journal-title":"J. Hepatobiliary Pancreat. Sci."},{"key":"84444_CR2","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1371\/journal.pmed.0040201","volume":"4","author":"B Sripa","year":"2007","unstructured":"Sripa, B. et al. Liver fluke induces cholangiocarcinoma. PLoS Med. 4, 1148\u20131155 (2007).","journal-title":"PLoS Med."},{"key":"84444_CR3","first-page":"1","volume":"15","author":"A Sivanand","year":"2023","unstructured":"Sivanand, A., Talati, D., Kalariya, Y., Patel, P. & Gandhi, S. K. Associations of liver fluke infection and cholangiocarcinoma: A scoping review. Cureus 15, 1\u20136 (2023).","journal-title":"Cureus"},{"key":"84444_CR4","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","volume":"17","author":"JM Banales","year":"2020","unstructured":"Banales, J. M. et al. Cholangiocarcinoma 2020: The next horizon in mechanisms and management. Nat. Rev. Gastroenterol. Hepatol. 17, 557\u2013588 (2020).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"84444_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-021-00300-2","volume":"7","author":"PJ Brindley","year":"2021","unstructured":"Brindley, P. J. et al. Cholangiocarcinoma. Nat. Rev. Dis. Primers 7, 1\u201317 (2021).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"84444_CR6","doi-asserted-by":"publisher","first-page":"4154","DOI":"10.3390\/ijms20174154","volume":"20","author":"H-J Wu","year":"2019","unstructured":"Wu, H.-J. & Chu, P.-Y. Role of cancer stem cells in cholangiocarcinoma and therapeutic implications. Int. J. Mol. Sci. 20, 4154 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"84444_CR7","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s13402-023-00770-4","volume":"46","author":"M de Souza-Ferreira","year":"2023","unstructured":"de Souza-Ferreira, M., Ferreira, \u00c9. E. & de Freitas-Junior, J. C. Aberrant N-glycosylation in cancer: MGAT5 and \u03b21,6-GlcNAc branched N-glycans as critical regulators of tumor development and progression. Cell. Oncol. 46, 481\u2013501 (2023).","journal-title":"Cell. Oncol."},{"key":"84444_CR8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1559-0275-8-7","volume":"8","author":"DL Meany","year":"2011","unstructured":"Meany, D. L. & Chan, D. W. Aberrant glycosylation associated with enzymes as cancer biomarkers. Clin. Proteom. 8, 7 (2011).","journal-title":"Clin. Proteom."},{"key":"84444_CR9","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1515\/cclm-2018-0379","volume":"57","author":"M Wang","year":"2019","unstructured":"Wang, M., Zhu, J., Lubman, D. M. & Gao, C. Aberrant glycosylation and cancer biomarker discovery: A promising and thorny journey. Clin. Chem. Lab. Med. 57, 407\u2013416 (2019).","journal-title":"Clin. Chem. Lab. Med."},{"key":"84444_CR10","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.3390\/ijms18091921","volume":"18","author":"J De-Freitas-Junior","year":"2017","unstructured":"De-Freitas-Junior, J., Andrade-da-Costa, J., Silva, M. & Pinho, S. Glycans as regulatory elements of the insulin\/IGF system: Impact in cancer progression. Int. J. Mol. Sci. 18, 1921 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"84444_CR11","doi-asserted-by":"publisher","first-page":"e66737","DOI":"10.1371\/journal.pone.0066737","volume":"8","author":"C Gomes","year":"2013","unstructured":"Gomes, C. et al. Expression of ST3GAL4 leads to SLex expression and induces c-Met activation and an invasive phenotype in gastric carcinoma cells. PLoS ONE 8, e66737 (2013).","journal-title":"PLoS ONE"},{"key":"84444_CR12","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.cell.2006.08.019","volume":"126","author":"K Ohtsubo","year":"2006","unstructured":"Ohtsubo, K. & Marth, J. D. Glycosylation in cellular mechanisms of health and disease. Cell 126, 855\u2013867 (2006).","journal-title":"Cell"},{"key":"84444_CR13","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.cellimm.2018.03.007","volume":"333","author":"JG Rodrigues","year":"2018","unstructured":"Rodrigues, J. G. et al. Glycosylation in cancer: Selected roles in tumour progression, immune modulation and metastasis. Cell. Immunol. 333, 46\u201357 (2018).","journal-title":"Cell. Immunol."},{"key":"84444_CR14","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.18632\/oncotarget.22377","volume":"9","author":"N Very","year":"2018","unstructured":"Very, N., Lefebvre, T. & el Yazidi-Belkoura, I. Drug resistance related to aberrant glycosylation in colorectal cancer. Oncotarget 9, 1380\u20131402 (2018).","journal-title":"Oncotarget"},{"key":"84444_CR15","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1002\/jcb.21608","volume":"104","author":"H Zhao","year":"2008","unstructured":"Zhao, H. et al. N-Glycosylation affects the adhesive function of E-Cadherin through modifying the composition of adherens junctions (AJs) in human breast carcinoma cell line MDA-MB-435. J. Cell. Biochem. 104, 162\u2013175 (2008).","journal-title":"J. Cell. Biochem."},{"key":"84444_CR16","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.trecan.2020.04.002","volume":"6","author":"AF Costa","year":"2020","unstructured":"Costa, A. F., Campos, D., Reis, C. A. & Gomes, C. Targeting glycosylation: A new road for cancer drug discovery. Trends Cancer 6, 757\u2013766 (2020).","journal-title":"Trends Cancer"},{"key":"84444_CR17","doi-asserted-by":"crossref","unstructured":"da Costa, V. et al. Lung tumor cells with different Tn antigen expression present distinctive immunomodulatory properties. Int. J. Mol. Sci. 23 (2022).","DOI":"10.3390\/ijms231912047"},{"key":"84444_CR18","doi-asserted-by":"publisher","first-page":"333","DOI":"10.21037\/atm.2018.07.16","volume":"6","author":"E Danese","year":"2018","unstructured":"Danese, E., Ruzzenente, A., Montagnana, M. & Lievens, P.M.-J. Current and future roles of mucins in cholangiocarcinoma\u2014Recent evidences for a possible interplay with bile acids. Ann. Transl. Med. 6, 333\u2013333 (2018).","journal-title":"Ann. Transl. Med."},{"key":"84444_CR19","doi-asserted-by":"crossref","unstructured":"Dombek, G. E. et al. Immunohistochemical analysis of Tn antigen expression in colorectal adenocarcinoma and precursor lesions. BMC Cancer 22 (2022).","DOI":"10.1186\/s12885-022-10376-y"},{"key":"84444_CR20","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3233\/CBM-130375","volume":"14","author":"T Ju","year":"2014","unstructured":"Ju, T., Aryal, R. P., Kudelka, M. R., Wang, Y. & Cummings, R. D. The Cosmc connection to the Tn antigen in cancer. Cancer Biomark. 14, 63\u201381 (2014).","journal-title":"Cancer Biomark."},{"key":"84444_CR21","doi-asserted-by":"crossref","unstructured":"Matsumoto, Y., Jia, N., Heimburg-Molinaro, J. & Cummings, R. D. Targeting Tn-positive tumors with an afucosylated recombinant anti-Tn IgG. Sci. Rep. 13 (2023).","DOI":"10.1038\/s41598-023-31195-6"},{"key":"84444_CR22","doi-asserted-by":"crossref","unstructured":"Rajesh, C. & Radhakrishnan, P. The (Sialyl) Tn antigen: Contributions to immunosuppression in gastrointestinal cancers. Front. Oncol. 12 (2023).","DOI":"10.3389\/fonc.2022.1093496"},{"key":"84444_CR23","doi-asserted-by":"crossref","unstructured":"Kinzler, M. N. et al. Expression of MUC16\/CA125 is associated with impaired survival in patients with surgically resected cholangiocarcinoma. Cancers. 14 (2022).","DOI":"10.3390\/cancers14194703"},{"issue":"4","key":"84444_CR24","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1046\/j.1440-1827.1999.00867.x","volume":"49","author":"M Sasaki","year":"1999","unstructured":"Sasaki, M., Yamato, T. & Nakanuma, Y. Expression of sialyl-Tn, Tn and T antigens in primary liver cancer. Pathol. Int. 49(4), 325\u2013331 (1999).","journal-title":"Pathol. Int."},{"key":"84444_CR25","doi-asserted-by":"crossref","unstructured":"Mishra, A. et al. Structure-function and application of plant lectins in disease biology and immunity. Food Chem. Toxicol. 134 (2019).","DOI":"10.1016\/j.fct.2019.110827"},{"key":"84444_CR26","first-page":"119","volume":"13","author":"S Indramanee","year":"2012","unstructured":"Indramanee, S., Silsirivanit, A., Pairojkul, C., Wongkham, C. & Wongkham, S. Aberrant glycosylation in cholangiocarcinoma demonstrated by lectin-histochemistry. Asian Pac. J. Cancer Prev. 13, 119\u2013124 (2012).","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"84444_CR27","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1093\/glycob\/cwz098","volume":"30","author":"M Detarya","year":"2020","unstructured":"Detarya, M. et al. The O-GalNAcylating enzyme GALNT5 mediates carcinogenesis and progression of cholangiocarcinoma via activation of AKT\/ERK signaling. Glycobiology 30, 312\u2013324 (2020).","journal-title":"Glycobiology"},{"key":"84444_CR28","first-page":"4140","volume":"12","author":"M Detarya","year":"2022","unstructured":"Detarya, M. et al. Emerging roles of GALNT5 on promoting EGFR activation in cholangiocarcinoma: A mechanistic insight. Am. J. Cancer Res. 12, 4140\u20134159 (2022).","journal-title":"Am. J. Cancer Res."},{"key":"84444_CR29","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/0031-9422(95)00535-F","volume":"40","author":"S Wongkham","year":"1995","unstructured":"Wongkham, S. et al. Isolectins from seeds of Artocarpus lakoocha. Phytochemistry 40, 1331\u20131334 (1995).","journal-title":"Phytochemistry"},{"key":"84444_CR30","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/glycob\/cwh144","volume":"15","author":"T Singh","year":"2005","unstructured":"Singh, T., Chatterjee, U., Wu, J. H., Chatterjee, B. P. & Wu, A. M. Carbohyrate recognition factors of a T\u03b1 (Gal\u03b21\u21923GalNAc\u03b11\u2192Ser\/Thr) and Tn (GalNAc\u03b11\u2192Ser\/Thr) specific lectin isolated from the seeds of Artocarpus lakoocha. Glycobiology 15, 67\u201378 (2005).","journal-title":"Glycobiology"},{"key":"84444_CR31","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s10719-008-9134-8","volume":"25","author":"U Chatterjee","year":"2008","unstructured":"Chatterjee, U., Bose, P. P., Dey, S., Singh, T. P. & Chatterjee, B. P. Antiproliferative effect of T\/Tn specific Artocarpus lakoocha agglutinin (ALA) on human leukemic cells (Jurkat, U937, K562) and their imaging by QD-ALA nanoconjugate. Glycoconj. J. 25, 741\u2013752 (2008).","journal-title":"Glycoconj. J."},{"key":"84444_CR32","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1007\/s001090050144","volume":"75","author":"GF Springer","year":"1997","unstructured":"Springer, G. F. Immunoreactive T and Tn epitopes in cancer diagnosis, prognosis, and immunotherapy. J. Mol. Med. 75, 594\u2013602 (1997).","journal-title":"J. Mol. Med."},{"key":"84444_CR33","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0304-3835(02)00691-2","volume":"195","author":"S Wongkham","year":"2003","unstructured":"Wongkham, S. et al. Serum MUC5AC mucin as a potential marker for cholangiocarcinoma. Cancer Lett. 195, 93\u201399 (2003).","journal-title":"Cancer Lett."},{"key":"84444_CR34","doi-asserted-by":"publisher","first-page":"5172","DOI":"10.1016\/S0021-9258(18)32554-7","volume":"258","author":"SE Tollefsen","year":"1983","unstructured":"Tollefsen, S. E. & Kornfeld, R. The B4 lectin from Vicia villosa seeds interacts with N-acetylgalactosamine residues alpha-linked to serine or threonine residues in cell surface glycoproteins. J. Biol. Chem. 258, 5172\u20135176 (1983).","journal-title":"J. Biol. Chem."},{"key":"84444_CR35","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1093\/jnci\/89.17.1260","volume":"89","author":"AF Chambers","year":"1997","unstructured":"Chambers, A. F. & Matrisian, L. M. Changing views of the role of matrix metalloproteinases in metastasis. J. Natl. Cancer Inst. 89, 1260\u20131270 (1997).","journal-title":"J. Natl. Cancer Inst."},{"key":"84444_CR36","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/227680a0","volume":"227","author":"UK Laemmli","year":"1970","unstructured":"Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680\u2013685 (1970).","journal-title":"Nature"},{"key":"84444_CR37","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1002\/ijc.25266","volume":"127","author":"S Prakobwong","year":"2010","unstructured":"Prakobwong, S. et al. Involvement of MMP-9 in peribiliary fibrosis and cholangiocarcinogenesis via Rac1-dependent DNA damage in a hamster model. Int. J. Cancer 127, 2576\u20132587 (2010).","journal-title":"Int. J. Cancer"},{"key":"84444_CR38","doi-asserted-by":"publisher","first-page":"3392","DOI":"10.3748\/wjg.v11.i22.3392","volume":"11","author":"B Sripa","year":"2005","unstructured":"Sripa, B. et al. Establishment and characterization of an opisthorchiasis-associated cholangiocarcinoma cell line (KKU-100). World J. Gastroenterol. 11, 3392\u20133397 (2005).","journal-title":"World J. Gastroenterol."},{"key":"84444_CR39","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/978-1-4939-7111-4_8","volume":"1626","author":"Z Ren","year":"2017","unstructured":"Ren, Z., Chen, J. & Khalil, R. A. Zymography as a research tool in the study of matrix metalloproteinase inhibitors. Methods Mol. Biol. 1626, 79\u2013102 (2017).","journal-title":"Methods Mol. Biol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84444-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84444-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84444-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T04:37:52Z","timestamp":1735965472000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84444-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,2]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["84444"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-84444-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,2]]},"assertion":[{"value":"23 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"436"}}